Meridiem Capital Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.68M Sell
40,741
-75,515
-65% -$15.7M 0.43% 71
2026
Q1
$24.6M Buy
+116,256
New +$25M 1.6% 24
2025
Q1
Sell
-101,609
Closed -$12M 65
2024
Q4
$12M Buy
+101,609
New +$11.9M 1.06% 35

Other funds holding CAH

Meridiem Capital Partners's CAH Position: Q2 2026 in Review

Meridiem Capital Partners reduced its Cardinal Health (CAH) stake by 65% in Q2 2026, selling an estimated $15.7M and leaving 40,741 shares worth $9.68M. The position accounts for 0.43% of the portfolio, ranked #71.

Meridiem Capital Partners first reported a position in CAH in Q4 2024 and has held it in 3 quarters since. The position peaked at $24.6M in Q1 2026. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Meridiem Capital Partners held 40,741 shares of Cardinal Health worth $9.68M as of Q2 2026.
  • Meridiem Capital Partners sold 75,515 Cardinal Health shares in Q2 2026, an estimated $15.7M.
  • Cardinal Health made up 0.43% of Meridiem Capital Partners's portfolio in Q2 2026, its #71 holding.
  • Meridiem Capital Partners first reported a position in Cardinal Health in Q4 2024 and has held it in 3 quarters since.
  • Meridiem Capital Partners's Cardinal Health position peaked at $24.6M in Q1 2026.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.